156 related articles for article (PubMed ID: 9542765)
1. Hepatitis B and C viruses: molecular identification and targeted antiviral therapies.
Berenguer M; Wright TL
Proc Assoc Am Physicians; 1998; 110(2):98-112. PubMed ID: 9542765
[TBL] [Abstract][Full Text] [Related]
2. Treatment predictors of a sustained virologic response in hepatitis B and C.
Kau A; Vermehren J; Sarrazin C
J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
[TBL] [Abstract][Full Text] [Related]
3. Coinfection by hepatitis B virus and hepatitis C virus.
Pontisso P; Gerotto M; Benvegnù L; Chemello L; Alberti A
Antivir Ther; 1998; 3(Suppl 3):137-42. PubMed ID: 10726063
[TBL] [Abstract][Full Text] [Related]
4. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
Chu CJ; Lee SD
J Gastroenterol Hepatol; 2008 Apr; 23(4):512-20. PubMed ID: 18397482
[TBL] [Abstract][Full Text] [Related]
8. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
9. Virology of hepatitis B and C viruses and antiviral targets.
Pawlotsky JM
J Hepatol; 2006; 44(1 Suppl):S10-3. PubMed ID: 16338022
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus: old, new and future approaches to antiviral treatment.
Karayiannis P
J Antimicrob Chemother; 2003 Apr; 51(4):761-85. PubMed ID: 12654750
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus genetic variability in patients undergoing antiviral therapy.
Cristina J; del Pilar Moreno M; Moratorio G
Virus Res; 2007 Aug; 127(2):185-94. PubMed ID: 17449128
[TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
13. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
[TBL] [Abstract][Full Text] [Related]
14. Existing and future therapeutic options for hepatitis C virus infection.
Bretner M
Acta Biochim Pol; 2005; 52(1):57-70. PubMed ID: 15827606
[TBL] [Abstract][Full Text] [Related]
15. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.
Lamarre D; Anderson PC; Bailey M; Beaulieu P; Bolger G; Bonneau P; Bös M; Cameron DR; Cartier M; Cordingley MG; Faucher AM; Goudreau N; Kawai SH; Kukolj G; Lagacé L; LaPlante SR; Narjes H; Poupart MA; Rancourt J; Sentjens RE; St George R; Simoneau B; Steinmann G; Thibeault D; Tsantrizos YS; Weldon SM; Yong CL; Llinàs-Brunet M
Nature; 2003 Nov; 426(6963):186-9. PubMed ID: 14578911
[TBL] [Abstract][Full Text] [Related]
16. Novel treatment options for hepatitis B virus infection.
Kumar R; Agrawal B
Curr Opin Investig Drugs; 2004 Feb; 5(2):171-8. PubMed ID: 15043391
[TBL] [Abstract][Full Text] [Related]
17. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
Yalcin K; Degertekin H; Yildiz F; Kilinc N
J Gastroenterol; 2003; 38(8):796-800. PubMed ID: 14505137
[TBL] [Abstract][Full Text] [Related]
18. Drug-resistant viral hepatitis.
Wright M; Main J; Thomas HC
J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
[No Abstract] [Full Text] [Related]
19. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
20. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]